Chi Chu, MD, MAS
Assistant Professor
Medicine
School of Medicine

Education & Training

Show all (6) Hide

• Fellowship Nephrology University of California, San Francisco 2021
• MAS Clinical Research University of California, San Francisco 2020
• Diversity, Equity, and Inclusion Champion Training University of California, San Francisco 2019
• Residency Internal Medicine California Pacific Medical Center 2017
• MD Medicine University of Massachusetts Medical School 2014
• AB Chemistry, Linguistics (minor) Dartmouth College 2010

Interests

Show all (6) Hide

• Healthcare Disparities
• Electronic Health Records
• Risk Prediction Modeling
• Healthcare Delivery
• Clinical Prediction Models
• Chronic Kidney Disease

Grants and Projects

Show all (4) Hide

• Targeted Automated Nephrology e-Consultation for Diabetic Kidney Disease, NIH, 2023-2027
• Risk-Based Care and Equity in Advanced Chronic Kidney Disease, National Kidney Foundation, 2021-2023
• UCSF Learning Health System K12 Career Development Program, NIH/AHRQ, 2022-2023
• Evaluating the Impact of Guidelines on Physician Prescription Practices in Chronic Kidney Disease, NIH, 2019-2021

Publications (24)

Top publication keywords:
Glomerular Filtration RateHospital Communication SystemsAlbuminuriaAwarenessAcute Coronary SyndromeText MessagingAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsRenal InsufficiencyProteinuriaNephrologyInterdisciplinary CommunicationHypertensionRenal Insufficiency, ChronicDiagnostic Techniques and Procedures

• Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.
  Clinical journal of the American Society of Nephrology : CJASN 2023 Drawz PE, Lenoir KM, Rai NK, Rastogi A, Chu CD, Rahbari-Oskoui FF, Whelton PK, Thomas G, McWilliams A, Agarwal AK, Suarez MM, Dobre M, Powell J, Rocco MV, Lash JP, Oparil S, Raj DS, Dwyer JP, Rahman M…
• Fulfillment and Validity of the Kidney Health Evaluation Measure for People with Diabetes.
  Mayo Clinic proceedings. Innovations, quality & outcomes 2023 Ferrè S, Storfer-Isser A, Kinderknecht K, Montgomery E, Godwin M, Andrews A, Dunning S, Barton M, Roman D, Cuddeback J, Stempniewicz N, Chu CD, Tuot DS, Vassalotti JA
• Equity is more powerful than equality in addressing disparities in kidney transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023 Powe NR, Chu CD, Segev DL
• Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease.
  JAMA network open 2023 Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, Gualtieri R, Liao N, Kong SX, Williamson T, Shlipak MG, Estrella MM
• Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in Advanced CKD.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2023 Chu CD, McCulloch CE, Hsu RK, Powe NR, Bieber B, Robinson BM, Raina R, Pecoits-Filho R, Tuot DS

Show all (19 more) Hide

• Kidney Function Trajectories and Health Care Costs: Identifying High-Need, High-Cost Patients.
  Kidney medicine 2023 Chu CD, Tuot DS, Tummalapalli SL
• Gaps in Nephrology Referral Care Utilization in Patients at High-Risk of Progression to Kidney Failure.
  AMIA ... Annual Symposium proceedings. AMIA Symposium 2023 Peter S, Wang M, Chu CD, Tuot DS, Chattopadhyay A, Chen JH
• Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record.
  Contemporary clinical trials 2023 Chu CD, Lenoir KM, Rai NK, Soman S, Dwyer JP, Rocco MV, Agarwal AK, Beddhu S, Powell JR, Suarez MM, Lash JP, McWilliams A, Whelton PK, Drawz PE, Pajewski NM, Ishani A, Tuot DS
• Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease.
  Diabetes care 2022 Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Chu CD, Peralta CA, Du Y, Singh R, Kong SX, Tuot DS, Shlipak MG, Estrella MM
• Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity.
  BMC primary care 2022 Chu CD, Powe NR, Shlipak MG, Scherzer R, Tummalapalli SL, Estrella MM, Tuot DS
• Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria.
  Mayo Clinic proceedings 2022 Chu CD, Powe NR, Estrella MM, Shlipak MG, McCoy IE, Tuot DS
• Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression.
  JAMA network open 2022 Wang M, Peter SS, Chu CD, Tuot DS, Chen JH
• Racial Differences in Medication Utilization for Secondary Prevention of Cardiovascular Disease in Kidney Transplant Recipients: A Post Hoc Analysis of the FAVORIT Trial Cohort.
  Kidney medicine 2022 Fallahzadeh MK, Ku E, Chu CD, McCulloch CE, Tuot DS
• Too Many for Too Few: Finding Appropriate Nephrology Referrals for Patients With CKD That Optimize Outcomes.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2022 Chu CD, Lamprea-Montealegre JA, Estrella MM
• Avoiding Overuse of Venipuncture and Laboratory Testing in Hospitalized Patients on Hemodialysis.
  Journal of patient safety 2022 Tummalapalli SL, Chu CD, Tuot DS
• Facilitating a Patient-Centered Transition From Kidney Disease to Kidney Failure: Can Digital Tools Help?
  Kidney medicine 2021 Chu CD, Tuot DS
• CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2021 Chu CD, Powe NR, Crews DC, Tuot DS
• Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019.
  JAMA network open 2021 Chu CD, Powe NR, McCulloch CE, Crews DC, Han Y, Bragg-Gresham JL, Saran R, Koyama A, Burrows NR, Tuot DS, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team
• Patient Awareness of CKD: A Systematic Review and Meta-analysis of Patient-Oriented Questions and Study Setting.
  Kidney medicine 2021 Chu CD, Chen MH, McCulloch CE, Powe NR, Estrella MM, Shlipak MG, Tuot DS
• Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria.
  Hypertension (Dallas, Tex. : 1979) 2020 Chu CD, Powe NR, McCulloch CE, Banerjee T, Crews DC, Saran R, Bragg-Gresham J, Morgenstern H, Pavkov ME, Saydah SH, Tuot DS, Centers for Disease Control and Prevention Chronic Kidney Disease …
• The Kidney Failure Risk Equation for Prediction of Allograft Loss in Kidney Transplant Recipients.
  Kidney medicine 2020 Chu CD, Ku E, Fallahzadeh MK, McCulloch CE, Tuot DS
• Completeness and quality of text paging for subspecialty consult requests.
  Postgraduate medical journal 2020 Chu CD, Tuot DS, Harrison JD, Duong J, Luxenberg A, Khanna RR
• CKD Awareness Among US Adults by Future Risk of Kidney Failure.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2020 Chu CD, McCulloch CE, Banerjee T, Pavkov ME, Burrows NR, Gillespie BW, Saran R, Shlipak MG, Powe NR, Tuot DS, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team
• Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes.
  American journal of nephrology 2019 Lee J, Chu C, Guzman D, Fontil V, Velasquez A, Powe NR, Tuot DS